SEB Asset Management AB »

Definium Therape shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.8M 208k 47.04

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Applied Materials (AMAT)

View all positions for SEB Asset Management AB

Top funds holding Definium Therape

BlackRock
venBio Select Advisor
Driehaus Capital Management
Jupiter Topco
FMR
Geode Capital Management
Henderson Group
Capital Research and Management Company - Division 3
Octagon Capital Advisors
Wellington Management Company
Deep Track Capital
State Street Corporation
Citadel Advisors
Commodore Capital
Susquehanna International

View all funds holding Definium Therape